Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy

被引:21
|
作者
Bilici, Ahmet [1 ,3 ]
Selcukbiricik, Fatih [2 ]
机构
[1] Istanbul Medipol Univ, Fac Med, Dept Med Oncol, Istanbul, Turkey
[2] Sisli Etfal Educ & Res Hosp, Dept Med Oncol, Istanbul, Turkey
[3] TEM Avrupa Otoyolu Goztepe Cikisi, TR-34214 Istanbul, Turkey
关键词
Proximal gastric cancer; Recurrence pattern; Prognosis; Survival; REGIONAL VARIATION; FOLLOW-UP; CARDIA; ADENOCARCINOMA; CARCINOMA;
D O I
10.1007/s13277-015-3304-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Proximal gastric cancer has a high propensity of early recurrence after curative resection due to high incidence of lymph node involvement. In the present study, we aimed to investigate the pattern and time of recurrence and to evaluate the risk factors for recurrence of patients with proximal gastric cancer. Between 2005 and 2013, 99 patients with recurrent proximal gastric cancer who underwent radical gastrectomy were retrospectively analyzed. The prognostic significance of the pattern and the time of recurrence and the relationship between the pattern of recurrence and the other clinicopathological factors were evaluated. The median time to recurrence was 24 months; 45.5 % of patients relapsed within 2 years. Forty-three (43.4 %) patients indicated hematogenous recurrence and 41 (41.4 %) patients revealed peritoneal recurrence with the most predominant patterns. The median progression-free survival (PFS) time for patients with locoregional recurrence was significantly better than that of patients with peritoneal recurrences, hematogenous recurrences, and distant lymph nodes (32.2 vs. 18.9 vs. 18.2 vs. 9.7 months, p = 0.005, respectively). Moreover, the median overall survival (OS) interval for patients with distant lymph nodes recurrence was significantly worse than that of patients with locoregional, peritoneal, and hematogenous recurrences (13.5 vs. 48.5 vs. 31.4 vs. 29.9 months, p = 0.006, respectively). The presence of lymph node metastasis (p = 0.004) and surgery type (p = 0.04) for PFS and the time of recurrence (p = 0.033), lymph node metastasis (p = 0.03), and surgery type (p = 0.04) for OS were found to be independent prognostic factors by multivariate analysis. Logistic regression analysis indicated that the presence of lymph node metastasis and surgery type were independent risk factors for predicting the occurrence of early recurrence (p = 0.001, OR 0.48 and p = 0.028, OR 0.41, respectively). The median OS time of early recurrence patients was significantly shorter than that of patients with late recurrence (16.6 vs. 55.2 months, p < 0.001). Furthermore, proximal gastrectomy, poorly differentiated histology, advanced pT stage, and lymph node metastasis were significantly associated with early recurrence. Our results showed that lymph node metastasis and surgery type were independent risk factors for prediction of early recurrence in proximal gastric cancer. Thus, total gastrectomy with regional lymph node dissection may be a suitable treatment option for proximal gastric cancer patients with tumors that have high risk features for recurrence.
引用
收藏
页码:6191 / 6199
页数:9
相关论文
共 50 条
  • [1] Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer.
    Bilici, Ahmet
    Selcukbiricik, Fatih
    Ustaalioglu, Bala Basak Oven
    Tural, Deniz
    Seker, Mesut
    Gumus, Mahmut
    Serdengecti, Suheyla
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Role of Recurrence Pattern Multiplicity in Predicting Post-recurrence Survival in Patients Who Underwent Curative Gastrectomy for Gastric Cancer
    Yang, Jun -Young
    Park, Ji-Hyeon
    Choi, Seung Joon
    Lee, Woon Kee
    [J]. JOURNAL OF GASTRIC CANCER, 2024, 24 (02) : 231 - 242
  • [3] The pattern and risk factors of recurrence of proximal gastric cancer after curative resection
    Li, Fangxuan
    Zhang, Rupeng
    Liang, Han
    Liu, Hui
    Quan, Jichuan
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (02) : 130 - 135
  • [4] Changes in Postoperative Recurrence and Prognostic Risk Factors for Patients with Gastric Cancer who Underwent Curative Gastric Resection during Different Time Periods
    Dae Hoon Kim
    Su Mi Kim
    Jung Kuk Hyun
    Min Gew Choi
    Jae Hyung Noh
    Tae Sung Sohn
    Jae Moon Bae
    Sung Kim
    [J]. Annals of Surgical Oncology, 2013, 20 : 2317 - 2327
  • [5] Changes in Postoperative Recurrence and Prognostic Risk Factors for Patients with Gastric Cancer who Underwent Curative Gastric Resection during Different Time Periods
    Kim, Dae Hoon
    Kim, Su Mi
    Hyun, Jung Kuk
    Choi, Min Gew
    Noh, Jae Hyung
    Sohn, Tae Sung
    Bae, Jae Moon
    Kim, Sung
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) : 2317 - 2327
  • [6] Recurrence Pattern of Gastric Cancer After Curative Gastrectomy
    Tan, Wee Boon
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S1103 - S1103
  • [7] Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy
    Aydin, D.
    Bilici, A.
    Yavuzer, D.
    Kefeli, U.
    Tan, A.
    Ercelep, O.
    Mert, A.
    Yuksel, S.
    Ozcelik, M.
    Isik, D.
    Surmeli, H.
    Odabasi, H.
    Aliustaoglu, M.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (08): : 604 - 611
  • [8] Prognostic significance of preoperative CT findings in patients with advanced gastric cancer who underwent curative gastrectomy
    Park, Chae Jung
    Seo, Nieun
    Hyung, Woo Jin
    Koom, Woong Sub
    Kim, Hyo Song
    Kim, Myeong-Jin
    Lim, Joon Seok
    [J]. PLOS ONE, 2018, 13 (08):
  • [9] Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy
    Bilici, Ahmet
    Aydin, Dincer
    Yavuzer, Dilek
    Odabas, Hatice
    Ercelep, Ozlem
    Yuksel, Sinemis
    Mert, Aslihan Guven
    Ozcelik, Melike
    Aliustaoglu, Mehmet
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [10] Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy
    D. Aydin
    A. Bilici
    D. Yavuzer
    U. Kefeli
    A. Tan
    O. Ercelep
    A. Mert
    S. Yuksel
    M. Ozcelik
    D. Isik
    H. Surmeli
    H. Odabasi
    M. Aliustaoglu
    [J]. Clinical and Translational Oncology, 2015, 17 : 604 - 611